Literature DB >> 7590873

Bystander suppression of the immune response to human serum albumin in rats fed ovalbumin.

A Dahlman-Höglund1, U Dahlgren, S Ahlstedt, L A Hanson, E Telemo.   

Abstract

Bystander suppression of delayed-type hypersensitivity (DTH) and the antibody response to human serum albumin (HSA) were studied in young normal rats and in young rats made partially tolerant to ovalbumin (OVA) by feeding an OVA-containing diet for 4 weeks from weaning. At 2 months of age, the animals were intracutaneously immunized with a mixture of OVA and HSA in Freund's complete adjuvant (FCA) at one site of the back, or separately at two different sites on the back. All rats made orally tolerant to OVA showed a significantly reduced IgE and IgG anti-OVA antibody production and DTH response to OVA, compared to the controls. OVA-fed rats subsequently immunized with a mixture of OVA + HSA had significantly lower IgE and DTH responses to HSA than the controls. When rats were immunized with OVA and HSA at two different sites, however, there was no difference in the response to HSA between the OVA-fed rats and the control rats, which rules out the possibility of shared epitopes between the antigens. Ear-challenge with the mixture of OVA + HSA gave a significantly lower DTH reaction in the tolerant rats immunized with a mixture of the antigens, compared to the control rats. However, suppression of the DTH reaction was not seen when tolerant and control rats were immunized with HSA alone and challenged with the mixture of OVA + HSA in one ear. These results present evidence that young rats orally tolerant to one antigen show a suppressed T-cell and antibody response to an unrelated antigen, provided that the two antigens are given in a mixture during the inductive phase. There was no evidence for bystander suppression of the T-cell response at the effector site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590873      PMCID: PMC1383820     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Difference between bacterial and food antigens in mucosal immunogenicity.

Authors:  A E Wold; U I Dahlgren; L A Hanson; I Mattsby-Baltzer; T Midvetdt
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Rats are sensitive to induction of tolerance by feeding only at young age.

Authors:  A E Wold; U I Dahlgren; S Ahlstedt; L A Hanson
Journal:  Monogr Allergy       Date:  1988

3.  Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.

Authors:  O Lider; L M Santos; C S Lee; P J Higgins; H L Weiner
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

4.  Down-regulation of immune responses to inhaled antigen: studies on the mechanism of induced suppression.

Authors:  J D Sedgwick; P G Holt
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

5.  Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered.

Authors:  S Strobel; A Ferguson
Journal:  Pediatr Res       Date:  1984-07       Impact factor: 3.756

6.  Immunoregulatory properties of antigenic fragments from bovine serum albumin.

Authors:  T A Ferguson; T Peters; R Reed; A J Pesce; J G Michael
Journal:  Cell Immunol       Date:  1983-05       Impact factor: 4.868

Review 7.  Oral tolerance.

Authors:  T B Tomasi
Journal:  Transplantation       Date:  1980-05       Impact factor: 4.939

8.  Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

Authors:  C C Whitacre; I E Gienapp; C G Orosz; D M Bitar
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

9.  Modulation of intestinal and systemic immune responses to a fed protein antigen, in mice.

Authors:  S Strobel; A Ferguson
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

10.  Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

Authors:  A Friedman; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

View more
  7 in total

1.  Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-beta) expression in the draining lymph nodes.

Authors:  B S Lundin; M R Karlsson; L A Svensson; L A Hanson; U I Dahlgren; E Telemo
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Immunoglobulin E suppression and cytokine modulation in mice orally tolerized to beta-lactoglobulin.

Authors:  S Pecquet; A Pfeifer; S Gauldie; R Fritsché
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

3.  Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma.

Authors:  Nina Almqvist; Anna Lönnqvist; Susanne Hultkrantz; Carola Rask; Esbjörn Telemo
Journal:  Immunology       Date:  2008-03-19       Impact factor: 7.397

4.  The ratio of n-6 to n-3 fatty acids in maternal diet influences the induction of neonatal immunological tolerance to ovalbumin.

Authors:  M Korotkova; E Telemo; Y Yamashiro; L A Hanson; B Strandvik
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

5.  Accelerated Clearance of Ultrasound Contrast Agents Containing Polyethylene Glycol is Associated with the Generation of Anti-Polyethylene Glycol Antibodies.

Authors:  Samantha M Fix; A Gloria Nyankima; Morgan D McSweeney; James K Tsuruta; Samuel K Lai; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2018-03-27       Impact factor: 2.998

6.  Oral administration of bovine whey proteins to mice elicits opposing immunoregulatory responses and is adjuvant dependent.

Authors:  A O Afuwape; M W Turner; S Strobel
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

7.  Bystander suppression of collagen-induced arthritis in mice fed ovalbumin.

Authors:  N Fredrik Bäckström; Ulf I H Dahlgren
Journal:  Arthritis Res Ther       Date:  2004-02-05       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.